KYTHERA Biopharmaceuticals to Present at the Goldman Sachs 35th Annual Global Healthcare Conference

        Print
| Source: KYTHERA Biopharmaceuticals, Inc.

CALABASAS, Calif., June 6, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman Sachs 35th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.

Event: Goldman Sachs 35th Annual Global Healthcare Conference

Date: Thursday, June 12, 2014

Time:  8:00 a.m. PT

A live webcast will be available under the Investors section of the Company's website at www.kytherabiopharma.com. The presentation will be archived on the website and will be available for at least 14 days.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is currently in late-stage development for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.

Investor Contact:
Heather Rowe
Associate Director, Investor Relations
Tel: (818) 587-4559